These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18451015)

  • 21. Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.
    Arora N; Knowles S; Gomes T; Mamdani MM; Juurlink DN; Carlisle C; Tadrous M
    Can J Psychiatry; 2016 Dec; 61(12):758-765. PubMed ID: 27310244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
    Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
    Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
    Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of antipsychotic medication use in Australia 2002-2007.
    Hollingworth SA; Siskind DJ; Nissen LM; Robinson M; Hall WD
    Aust N Z J Psychiatry; 2010 Apr; 44(4):372-7. PubMed ID: 20307170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatric prescribing trends and practices in Iowa's prisons.
    Lund BC; Flaum M; Adam LA; Perry PJ
    Psychiatr Serv; 2002 Aug; 53(8):1023-4. PubMed ID: 12161679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.
    Sernyak MJ; Rosenheck RA
    Psychiatr Serv; 2008 May; 59(5):567-9. PubMed ID: 18451019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy.
    Percudani M; Barbui C; Fortino I; Petrovich L
    Pharmacopsychiatry; 2005 May; 38(3):128-31. PubMed ID: 15902584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antipsychotic prescribing in schizophrenia in Auckland.
    Wheeler A; Humberstone V; Robinson G
    Australas Psychiatry; 2006 Jun; 14(2):169-74. PubMed ID: 16734645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
    Humberstone V; Wheeler A; Lambert T
    Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
    McCombs JS; Luo M; Johnstone BM; Shi L
    Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements.
    Law MR; Ross-Degnan D; Soumerai SB
    Psychiatr Serv; 2008 May; 59(5):540-6. PubMed ID: 18451014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agents.
    Gianfrancesco F; Durkin MB; Mahmoud R; Wang RH
    Pharmacoeconomics; 2002; 20(6):413-27. PubMed ID: 12052100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who are the new users of antipsychotic medications?
    Domino ME; Swartz MS
    Psychiatr Serv; 2008 May; 59(5):507-14. PubMed ID: 18451006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts.
    Martin BC; Miller LS; Kotzan JA
    Schizophr Res; 2001 Mar; 47(2-3):281-92. PubMed ID: 11278146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
    Offord S; Lin J; Mirski D; Wong B
    Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Need for therapeutic guidelines for antipsychotics under a prescription cap.
    Sutherland LG
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S19-22. PubMed ID: 9872690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.